Costco can save you 50% on these articles, said a study
Health plans and taxpayers are often too exhausted for drugs, say researchers.
Even if you are not a costco client, you have probably heard about the following worship of their free samples, their pizza cakes and birthday. But the chains of the warehouse club and other channels like this - could become known as destination of the destination of a different type: for inexpensive generic prescription drugs, which are often cheaper than Medicare .
The researchers at the USC School of the Pharmacy compared what the plans of the Medicare part paid for the most common generic requirements, including out-of-pocket payments, at cash prizes paid by members of the members of the members of the Costco for the same prescriptions in 2017 and 2018. They found Costco prices were cheaper 50% of the time.
The reason?Intermediaries who negotiate drug prices for Medicare do not transmit savings to people who need these medications, say the researchers.
"Our analysis shows that, in systems such as Costco, where incentives are configured to offer a value directly to the consumer at the counter of the pharmacy, this is what happens," said Erin Trish, Associate Director of the Center D USC Schaeffer's health and economy economy and an assistant professor of pharmaceutical and health economy at the USC School of the Pharmacy. "It's time to solve these incentives in the system of the Medicare part to put the patient first."
RELATED:Sure sign that you have "Long" Covid and may even know.
Medicare plans, overpower taxpayers for generics
The study revealed that from 1.4 billion medicines of 184 medicines, medicare plans fly over 13% in 2017 and nearly 21% in 2018 compared to the price of COSTCO members. And Medicare plans paid more than COSTCO members on nearly 53% of 90-day prescription fillers analyzed in 2018. Plans of 30 and 90 days, medicare plans are overlet 43%.
"Efforts to reduce prescription drug prices tend to focus on branded name drugs, but the opaque pharmaceutical supply system can also cause health plans and taxpayers to overcome generics," Declared Geoffrey Joyce, Director of Health Policy at the Center and President of the USC Schaeffer. From the Department of the Pharmaceutical Economy and Health at the USC School of the Pharmacy.
RELATED: Without a sign that you can have dementia, according to the CDC
How can this happen?
Medicare Part D is administered by private plans using intermediaries, called Pharmacy Benefit Managers (PBMS) to negotiate prescription drug prices on behalf of Medicare. But the PBMS does not seem to transmit these economies negotiated to the plans and patients.
"There is a lot of price competition among manufacturers for these medications, but that competition does not benefit the consumer," said Karen van Nuys, Executive Director of the Science Science Sciences Innovation Program Schaeffer Center and Assistant Professor at the USC Public Policy Award School. "These are not small market drugs where there could be a single supplier who can name its price."
Legislators should look closer to negotiators, researchers say in this month.JAMA internal medicine.And to cross the healthiest life, do not miss these13 daily habits that kill you secretly.